Little is known about the natural history of human papillomavirus (HPV) infection in male virgins. This study estimated the incidence and clearance of genital HPV infection and the factors associated with these measures among men who denied at baseline ever having penetrative sex.
Approximately 14 million people in the United States become newly infected every year with human papillomavirus (HPV) [1] . HPV can cause high-grade cervical intraepithelial neoplasia, invasive cervical cancer, and vulvar, vaginal, anal, penile, and oral cancers, in addition to anogenital warts and recurrent respiratory papillomatosis [2] .
HPV transmission requires the presence of epithelial microtraumas, which allow HPV to reach basal cells at the bottom of the epidermis. These infected cells divide and produce daughter cells that are pushed to the outer epidermal layer. As this layer is sloughed off, infected cells are released into the environment or passed on to other skin/mucosal surfaces [2, 3] .
HPV is transmitted primarily through penetrative sex [1] , although there is evidence of other modes of transmission, namely mother-to-infant transmission, nonsexual skinto-skin contact, nonpenetrative sexual transmission, and contact with HPV-contaminated fomites [2, 4] . Our prior investigation observed a substantial prevalence of genital HPV in men (25.0%) who denied any history of penetrative sex [5] . Little else is known about HPV infection among male virgins and the acquisition of HPV after male sexual debut. Studying the natural history of HPV infection among those men may help us better understand HPV transmission and thus be beneficial in the prevention of HPV-related disease.
Our aim was to determine the incidence, persistence and clearance of genital HPV infection among male virgins at baseline in the HPV Infection in Men (HIM) Study cohort during a 6-year follow-up period and to identify factors associated with incidence and clearance.
METHODS

Study Population
From June 2005 to September 2009, healthy men were recruited from Tampa, Florida; São Paulo, Brazil; and Cuernavaca, Mexico. The study population consisted of men who met the following inclusion criteria: age of 18-70 years; residence in southern Florida, São Paulo, or Cuernavaca; no prior diagnosis of penile cancer, anal cancer, or genital warts; no symptoms of a sexually transmitted infection (STI) or treatment for an STI at enrollment; no participation in an HPV vaccine study; no history of human immunodeficiency virus infection or AIDS; no history of imprisonment, homelessness, or drug treatment during the past 6 months; no plans to relocate within the next 4 years; and willingness to comply with 10 scheduled visits every 6 months for 4 years. Eligible men provided informed consent with the help of a trained study team member. All study procedures were approved by the human-subjects' committees at each study site. All men received nominal compensation for their participation.
Data Collection
Risk Factor Questionnaire
At enrollment, men completed an 88-item computer-assisted self-interview (CASI) to collect information on sociodemographic characteristics, sexual behavior history, alcohol and tobacco consumption, and condom use practices. At each follow-up visit, participants completed a similar CASI questionnaire about their substance use and sexual behavior since the prior visit.
HPV Genital Sampling and Genotyping
At each visit, 3 different prewetted polyethylene terephthalate-tipped swabs were used to sample the glans penis/coronal sulcus, the shaft, and the scrotum of participants, and swab specimens were later combined to produce a single sample for the detection of genital HPV. All samples were stored at −80°C until genotyping. Samples underwent DNA extraction using the QIAamp DNA Mini Kit (Qiagen, Valencia, CA). Briefly, 200-µL aliquots of samples were digested with 20 µL of proteinase K solution for 1 hour at 65°C, followed by 200 µL of lysis buffer [6] . Polymerase chain reaction (PCR) analysis was performed within 36 hours after extraction. Samples were tested for the presence of HPV, using the PCR consensus primer system (PGMY 09/11) [7] . HPV genotyping was conducted using the Linear Array assay (Roche Diagnostics, Indianapolis, IN) by amplifying 50 µL of the DNA extracts to detect 36 HPV types. All plates included negative (nontemplate controls) and positive controls (CaSki) to control for possible contamination. Only samples that tested positive for β-globin or an HPV genotype were considered adequate and included in the analysis. HPV types 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, and 68 were classified as high risk, and HPV types 6, 11, 26, 34, 40, 42, 44, 53, 54, 61, 62, 66, 67, 69, 70, 71, 72, 73, 81, 82, 83, 84 , and 89 as low risk. While oral and anal specimens were collected from a subset of men in the HIM study, this analysis relied on genital specimens collected from all men at every study visit.
Data Analysis
Men were classified as virgins (n = 88) or nonvirgins (n = 3834) at baseline (Supplementary Figure 1) . The criteria have been described in detail elsewhere [5] . Specifically, men were defined as virgins at baseline if they (1) denied any history of penetrative vaginal, oral, and anal sexual intercourse; (2) had negative results of all study-based tests for sexually transmitted infections (other than HPV); (3) self-reported being HIV negative; (4) had a marital status of single, never married; and (5) were negative for HPV 6, 11, 16, and 18 antibodies. Men were defined as virgins not initiating sex if they reported no penetrative sex during follow-up. Men were defined as virgins initiating sex if they reported any penetrative sex during follow-up. Only men with HPV test results and sexual behavior information during follow-up visits were included for analysis.
Potential risk factors based on previous male HPV studies were selected for analyses, including age (continuous), residence, race, ethnicity, education level, number of alcoholic drinks in the past month, cigarette smoking status, circumcision status, and number of sex partners. The number of alcoholic drinks in the past month was categorized as 0, 1-60, and >60 drinks [8] . Men who smoked >100 cigarettes in their lifetime and currently smoke were classified as current smokers. Men who smoked >100 cigarettes in their lifetime but did not smoke at baseline were classified as former smokers, and the rest were classified as never smokers.
Only men who tested negative at baseline for any type-specific HPV infection were included in incidence analysis. The first positive HPV test result following a type-specific negative HPV test result at baseline was considered indicative of incident HPV infection. The first positive HPV test result after sexual debut among individuals for whom all prior HPV test results were negative was considered indicative of incident HPV infection after sexual debut. A positive test result for any of the 36 HPV genotypes was considered indicative of incident infection with any HPV type. A positive test result for at least 1 high-risk HPV genotype was considered indicative of incident infection with a high-risk HPV type. A positive test result for at least 1 low-risk HPV genotype was considered indicative of incident infection with a low-risk HPV type. The analytical unit was an individual since only the first incident infection was considered. The time to HPV infection was estimated as the difference between the date of cohort entry and the date of HPV acquisition. Men who were free of HPV infection at the last visit were censored. The time to sexual debut was estimated as the difference between the date of study entry and the date of the visit when penetrative sex was first reported. For example, if a virgin at visit 1 initiated sex at visit 3, then the time to sexual debut would be the interval from visit 1 to visit 3. The time to HPV infection after sexual debut was estimated as the difference between the date of the visit when sexual debut was reported and the date of the subsequent visit when HPV infection was first detected in the participant. The cumulative risk of incident HPV infection was estimated using the Kaplan-Meier method with log-rank tests used to identify differences in incidence between virgins who did and those who did not initiate sex during the follow-up period. The 95% confidence intervals (CIs) for incidence rates were calculated on the basis of the number of events modeled as a Poisson variable for the total person-months. Incidence rates were not adjusted.
Persistent infection was defined as at least 2 consecutive positive HPV type-specific test results with an interval of ≥6 months between tests. For persistence analyses, the analytic unit was an individual. Both incident and prevalent infections were included. The Mantel-Haenszel χ 2 test for trend was used to test the trend of persistent infection among nonvirgins, virgins initiating sex, and virgins not initiating sex, given their ordinal nature (ie, nonvirgins had established sexual behavior, virgins initiating sex had newly initiated sexual behavior, and virgins not initiating sex had no sexual behavior).
For clearance analyses, the analytical unit was the infection because an individual could have multiple HPV genotype infections, with each genotype considered as a separate infection. Two consecutive negative HPV test results following a positive HPV test result was considered indicative of HPV clearance. Infections detected for the first time at the last visit were excluded. The time to HPV clearance was approximated by the difference between the time of the first positive HPV test result and the time of the first negative test result among the 2 consecutive tests with negative results. The clustered Kaplan-Meier method was used to estimate the median number of months to clearance for any HPV type. Men whose HPV infection was not cleared by the last visit were censored. The number of sex partners was entered in the model as a time-varying covariate. Prevalent HPV infections at baseline were adjusted for in the models, to control the impact of HPV infection status at baseline on HPV clearance.
The association between possible risk factors and HPV incidence and HPV clearance was assessed with hazard rates derived from Cox proportional hazards models, using a robust covariance matrix estimator and including number of sex partners as a time-varying covariate. For all modeling, factors with a P value of < .25 from bivariate analysis were included in multivariable regression using complete case analysis. Directed acyclic graphs [9, 10] identified age and country of residence as potential confounders, and both variables were retained in all multivariable models. A backward variable selection method was used to remove, one by one, variables that were not statistically significant (ie, those with P value of > .05). The proportional hazards assumption for all independent variables was examined by log-log survival curves. Data cleaning and statistical analysis were conducted using SAS software (version 9.4; SAS Institute, Cary, NC) and R (version 3.2.4, revised; R Project for Statistical Computing). All statistical tests were 2-sided and used an α threshold of 0.05.
RESULTS
Of 88 virgins at baseline, one was excluded from analysis because of missing information on sexual behavior during follow-up visits. Of the remaining 87 virgins, 72.4% were aged 18-24 years, 64.4% resided in Tampa, 49.4% were white, 71.3% were non-Hispanic, 82.8% never smoked, and 60.9% initiated (Figure 1) .
Among virgins initiating sex during follow-up, 28.7% and 45.5% acquired any HPV infection within 12 and 24 months, respectively, of sex initiation. In comparison, 9.8% and 28.8% of virgins not initiating sex and 35.6% and 52.5% of nonvirgins acquired any HPV infection within 12 and 24 months, respectively, although the difference was not statistically significant ( Figure 2) .
The (Table 3) .
After combining virgins initiating sex and virgins not initiating sex, bivariate analysis including number of sex partners as a time-varying covariate revealed that acquisition of any HPV infection was significantly higher among men with >1 female sex partner in the past 6 months, compared with men who had 0 sex partners in the past 6 months (Table 4) . Virgins who were current smokers at baseline were more likely than never smokers Men who were older (vs younger), men reporting 1 female sex partner (vs 0) in the past 6 months, and men with incident (vs prevalent) HPV infection at baseline were less likely to clear a high-risk HPV infection in multivariable analysis (Table 5) . Also, virgins who were current smokers at baseline were 2.12 times (95% CI, 1.16-3.89) more likely than never smokers to clear a high-risk HPV infection. No factors were associated with lowrisk HPV clearance and acquisition of HPV infection (data not shown).
DISCUSSION
This study followed men in 3 countries for up to 6 years and observed incident genital HPV infection among male virgins not initiating sex and rapid acquisition of genital HPV among men initiating sex. Within 24 months of sexual debut, nearly half of virgins initiating sex acquired HPV. Genital HPV infection was more likely to persist in nonvirgins than in virgins initiating sex and virgins not initiating sex. The probability of clearing a high-risk HPV infection among virgins was significantly associated with younger age, current smoking, 0 female sex partners in the past 6 months, and prevalent HPV infection at baseline. While we are not aware of published data on HPV incidence among male virgins, 4 cohort studies reported the incidence of HPV infection among female virgins [11] [12] [13] [14] . A study of 148 university female students aged 18-20 years in the United States found that the 24-month cumulative incidence of HPV infection in virgins not initiating sex (n = 54) was 2.4% [11] . Another cohort study in the United States that followed girls aged 14-17 years every 3 months, with a median follow-up time of 5.2 years, detected HPV in 10 of 22 virgins not initiating sex (45.5%) during follow-up visits [13] . A cohort study of female students aged 16-25 years in Korea observed that 13% of 118 virgins not initiating sex had HPV infection at the 1.5-year follow-up visit [12] . A study among 109 Tanzanian girls aged 15-16 years before sexual debut reported an HPV incidence of 23.3 cases/1000 person-months [14] . The acquisition of HPV infection in virgins in these studies and the male virgins in our study suggests that transmission occurs in the absence of penetrative sexual behavior, possibly through nonpenetrative sexual behavior, such as hand-genital and genital-genital contact. Nonpenetrative sexual contact is common among virgins, with a study of adolescent virgins reporting that approximately 30% of self-reported virgins had engaged in masturbation with a partner in the last year [15] . Winer et al [11] reported that any type of nonpenetrative sexual contact increased the risk of HPV infection in female virgins. While comparisons between these female studies and our study are difficult, in the present study, after penetrative sex initiation, 45.5% of men acquired HPV within 24 months, which is similar to the 24-month incidence (38.9%) reported in the study by Winer et al [11] .
Persistent infections rarely occurred in men who did not initiate sex. Among virgins not initiating penetrative sex during follow-up, only 2 (5.9%) had incident infections due to any HPV type persisting for at least 6 months. This is a significantly lower proportion than among virgins initiating sex (27.8%) and nonvirgins (44.1%). This pattern of persistence is consistent with the idea that virgins not initiating sex may have had HPV deposition that did not involve infection of a basal cell, which is a necessary event for HPV to have a productive life cycle [3] .
In our study, age was inversely associated with clearance of high-risk HPV infection among men who, at study baseline, had not initiated sex. Generally, age is not associated with HPV acquisition and clearance in sexually experienced men [6, 16] , except that one study reported that the likelihood of HPV type 6 and 16 clearance increased significantly for sexually experienced men aged 55-70 years [17] .
The present study found a positive association between current smoking at baseline and clearance of high-risk HPV in baseline virgins. However, other HIM study data suggest that smoking was not associated with HPV clearance in primarily nonvirgins [18] . It is possible that current smoking at baseline is a surrogate for other unmeasured behaviors, such as nonpenetrative sexual behaviors.
Men with prevalent HPV infection at baseline were more likely than men with incident infection to clear any type and high-risk HPV infection. In additional analysis (data not shown), this association between prevalent or incident infection and clearance did not change after examining virgins initiating sex and virgins not initiating sex separately for any type HPV clearance (hazard ratio, 0.51 [95% CI, .20-1.31] for virgins initiating sex and 0.09 [95% CI, .01-1.10] for virgins not initiating sex). This is contrary to previous findings among sexually experienced men that prevalent HPV infection is less likely than incident HPV infection to clear [19] . One possible reason is that prevalent HPV infection in male virgins may more likely represent simple HPV deposition, whereas prevalent infection among sexually experienced men may more likely reflect The unit of analysis was the infection. Only incident HPV infections were included in the clearance analysis.
Abbreviations: CI, confidence interval; HR, hazard ratio; NE, not estimable.
a Estimated by Cox proportional hazards model, with nonvirgins as the reference group.
b The 95% CI does not include unity.
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infection of basal cells of the epidermis [3] . Whereas incident detection of HPV is more likely to represent productive infection occurring after sexual debut (rather than nonproductive infections occurring as a result of deposition). This is also in accordance with the present finding that a lower proportion of HPV persisted in virgins not initiating sex than in virgins initiating sex and nonvirgins. Another alternative explanation is that virgins who acquire HPV may be more likely to be a Prevalent (n = 41) and incident (n = 100) infections were included in clearance analysis. The unit of analysis for clearance was the infection.
c A total of 37 of 41 cleared infections. The median time to clearance was 0.9 months, and the median follow-up time was 40.1 months.
d A total of 87 of 100 cleared infections. The median time to clearance was 6.2 months, and the median follow-up time was 40.4 months.
e Categories 1 and >1 were combined for clearance analyses.
immunologically naive than virgins with prevalent infection, as supported by our finding that prevalent infection was not associated with 4-valent vaccine type clearance in male virgins testing negative for HPV 6, 11, 16, and 18 antibodies at baseline; however, prior HIM study analyses did not find natural immunity to be protective against HPV acquisition [20, 21] . This study is the first to examine HPV incidence, persistence, and clearance among male virgins. One strength is the inclusion of time-varying covariates in a Cox proportional hazards model to account for the change of behavior between multiple follow-up visits. Limitations include the small sample size (n = 87) and therefore lower statistical power for detecting potential risk factors, especially factors with sparse data, such as cigarette smoking, in which 72 men (82.8%) were never smokers and only 5 (5.7%) were ever smokers. Also, sexually active men may have been misclassified as virgins. However, the percentage of virgins (4.7%) in a recent population-based survey in the United States among males aged 20-44 years [22] was higher than in this study (2.2%). Possibly more likely is that men who are virgins might claim penetrative sexual behavior, given social desirability bias [23, 24] ; however, CASIs are known to reduce this bias [25, 26] . Another limitation is the possibility that HPV acquisition and clearance were underestimated owing to use of a 6-month interval for follow-up visits. Men might be infected and clear an infection between visits. Additionally, the estimates for the association might be biased without adjustment for effects of unmeasured nonpenetrative sexual behavior that could still transmit HPV. The estimates for the association might also be biased, even though sex initiation was adjusted for by the number of recent female sex partners. Last, the generalizability of the study results may be limited because most male virgins were from Tampa, were non-Hispanic, and were white.
In conclusion, virgins acquired low-risk HPV infections significantly more slowly than nonvirgins. Virgins not initiating sex cleared any high-risk, 4-valent vaccine, and 9-valent vaccine HPV types significantly faster than nonvirgins. It is postulated that nonpenetrative sexual contact is a possible route for HPV acquisition among virgins not initiating sex, although these infections may include detection of nonproductive infections. After penetrative sex initiation, 45.5% of men acquired HPV within 24 months, which is similar to findings reported for women. These findings highlight the rapid acquisition of HPV after sexual debut among men and thus emphasize the importance of HPV vaccination before sexual debut. However, as men remain at risk for HPV infection throughout their lives, HPV vaccination at older ages provides benefit. Future prospective studies with a larger sample of virgins that collect information on nonpenetrative sex behavior (eg, penile-hand contact, penile-vulvar contact, and deep kissing) and sample HPV from nonpenile sites (eg, hand, oral, and anal sites) are necessary to better understand HPV transmission among virgins.
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Notes
Abbreviations: aHR, adjusted hazard ratio; NA, not applicable (ie, variable was not included in the multivariable model); NE, not estimable (ie, 0 events for that variable).
a The 95% CI does not include unity.
